Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsWhat you need to know about Johnson & Johnson’s 2017 full-year earnings report
      FINAL LEDE- What You Need to Know About Johnson & Johnson's 2017 Full-Year Earnings Report- Earnings Illustration 2

      What you need to know about Johnson & Johnson’s 2017 full-year earnings report

      See how the company’s consumer, pharmaceutical and medical devices businesses performed in 2017 in this breakdown of its latest annual earnings report.

      Share Article
      share to

      Johnson & Johnson shared financial information this morning about its full-year performance in 2017.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

      For more details about the company’s 2017 results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.


      2017 Full Year Earnings Report Infographic

      Johnson & Johnson’s 2017 Earnings

      Read the earnings press release, which includes full financial data for 2017.

      Want to see more company earnings information? Find several years of Johnson & Johnson quarterly and full-year results here.

      More from Johnson & Johnson

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.

      What is a gene mutation?

      Experts aren’t sure why, but sometimes changes in DNA can trigger cancer to grow and spread. For DNA Day learn all about gene mutations—and Johnson & Johnson’s work developing new therapies to target these specific types of cancer.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.